
Tumors of the Central Nervous System, Volume 2
Kurzinformation



inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
Advantages and limitations of biomarkers in gliomagenesis are described. Molecular subtypes of gliomas are detailed. The role played by TP53 gene mutation in the deadliest brain tumor, glioblastoma multiforme, is pointed out. The role of mutations of IDH1 and IDH2, and isocitrate dehydrogenases in malignant gliomas are presented. Metabolic differences in different regions of the glioma tumor are clarified. Various types of imaging modalities, including PET and SPECT, to diagnose gliomas in general and glioblastoma in particular in patients are explained in detail. Both low-grade and high-grade gliomas are discussed. Conventional as well as fluorescent-guided resection techniques for high-grade, recurrent malignant gliomas are detailed. Impact of resection extent on outcomes in patients with high-grade gliomas is clarified. The advantage of the use of intraoperative low-field MRI in glioma surgery is explained. von Hayat, M. A.
Produktdetails

So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
- Leinen
- 600 Seiten
- Erschienen 1995
- Thieme
- Gebunden
- 234 Seiten
- Erschienen 2018
- Thieme
- hardcover
- 404 Seiten
- Erschienen 1987
- Lippincott Williams and Wil...
- Leinen
- 371 Seiten
- Erschienen 1984
- Thieme
- hardcover
- 2496 Seiten
- Erschienen 2000
- Churchill Livingstone
- Hardcover -
- Erschienen 2013
- Wiley-VCH
- hardcover
- 576 Seiten
- Erschienen 2010
- Wiley-Blackwell
- hardcover
- 1875 Seiten
- Erschienen 2011
- Saunders
- hardcover
- 800 Seiten
- Erschienen 2002
- Thieme
- Kartoniert
- 418 Seiten
- Erschienen 2017
- Springer
- Kartoniert
- 402 Seiten
- Erschienen 2021
- Thieme